Eosinophil-derived interferon-lambda contributes to initiation of allergen-related inflammation in the intestine

Cytokine

Volumn 58, Issue 2, 2012, Pages 186-192

  He, Shao Heng ^a   Song, Chun Hua ^b   Liu, Zhigang ^c   Zhang, Huiyun ^a   Ma, Wenjing ^a   Zhou, Lin Fu ^a   Mahmood, Tahrin ^b   Yang, Ping Chang ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MCMASTER UNIVERSITY   (Canada)

^c Shenzhen University   (China)

Author keywords

Eosinophil; Epithelial barrier; Food allergy; Interferon lambda; T helper 2 response

Indexed keywords

ALLERGEN; FOOD ANTIGEN; INTERFERON; INTERFERON LAMBDA; LIPOPOLYSACCHARIDE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; EOSINOPHIL; EPITHELIUM CELL; FOOD ALLERGY; HUMAN; HUMAN TISSUE; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TH2 CELL;

ALLERGENS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; INTERFERONS; INTESTINES; MICE; MICE, INBRED BALB C;

EID: 84862819877     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.01.003     Document Type: Article

References (28)

1. Zareie M., Johnson-Henry K., Jury J., Yang P.C., Ngan B.Y., McKay D.M., et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006, 55:1553-1560.
2. Yang P.C., Jury J., Soderholm J.D., Sherman P.M., McKay D.M., Perdue M.H. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006, 168:104-114.
3. Collier-Hyams L., Neish A. Intestinal epithelial barrier and mucosal immunity. Cell Mol Life Sci 2005, 62:1339-1348.
4. Maresca M., Yahi N., YounFs-Sakr L., Boyron M., Caporiccio B., Fantini J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1[beta] effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol 2008, 228:84-92.
5. Vickery B.P., Chin S., Burks A.W. Pathophysiology of food allergy. Pediatr Clin North Am 2011, 58:363-376.
6. He S.H., Chen X., Song C.H., Liu Z.Q., Zhou L.F., Ma W.J., et al. Interferon-[lambda] mediates oral tolerance and inhibits antigen-specific, T-helper 2 cell-mediated inflammation in mouse intestine. Gastroenterology 2011, 141:249-258.
7. Li Q., Kawamura K., Ma G., Iwata F., Numasaki M., Suzuki N., et al. Interferon-[lambda] induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents. Eur J Cancer 2010, 46:180-190.
8. Srinivas S., Dai J., Eskdale J., Gallagher G.E., Megjugorac N.J., Gallagher G. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 2008, 125:492-502.
9. Mennechet F.J.D., Uze G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006, 107:4417-4423.
10. Pott J., Mahlakoiv T., Mordstein M., Duerr C.U., Michiels T., Stockinger S., et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA 2011, 108:7944-7949.
11. Wang J., Oberley-Deegan R., Wang S., Nikrad M., Funk C.J., Hartshorn K.L., et al. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda1) in response to influenza A infection. J Immunol 2009, 182:1296-1304.
12. Remedios M., Jones D., Kerlin P. Eosinophilic oesophagitis: epidemiology, pathogenesis and management. Drugs 2011, 71:527-540.
13. Plotz S.G., Lentschat A., Behrendt H., Plotz W., Hamann L., Ring J., et al. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 2001, 97:235-241.
14. Li Y., Efferson C., Ramesh R., Peoples G., Hwu P., Ioannides C. A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455). Cancer Immunol Immunother 2011, 60:515-524.
15. Lamousé-Smith E.S., Furuta G.T. Eosinophils in the gastrointestinal tract. Curr Gastroenterol Rep 2006, 8:390-395.
16. Di Leo V., Yang P.C., Berin M.C., Perdue M.H. Factors regulating the effect of IL-4 on intestinal epithelial barrier function. Int Arch Allergy Immunol 2002, 129:219-227.
17. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005, 129:550-564.
18. Smyth D., Phan V., Wang A., McKay D.M. Interferon-[gamma]-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn. Lab Invest 2011, 91:764-777.
19. Mashukova A., Wald F.A., Salas P.J. Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanism. Mol Cell Biol 2011, 31:756-765.
20. Groschwitz K.R., Hogan S.P. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009, 124:3-20.
21. Keita A., Soderholm J.D. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 2010, 22:718-733.
22. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006, 290:G496-G504.
23. Lotz M., Gütle D., Walther S., Ménard S., Bogdan C., Hornef M.W. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006, 203:973-984.
24. Melmed G., Thomas L.S., Lee N., Tesfay S.Y., Lukasek K., Michelsen K.S., et al. Human intestinal epithelial cells are broadly unresponsive to toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003, 170:1406-1415.
25. Wang J., Ouyang Y., Guner Y., Ford H.R., Grishin A.V. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol 2009, 183:1384-1392.
26. Hitotsumatsu O., Ahmad R.C., Tavares R., Wang M., Philpott D., Turer E.E., et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 2008, 28:381-390.
27. Yang P.C., Xing Z., Berin C.M., Soderholm J.D., Feng B.S., Wu L., et al. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 2007, 133:1522-1533.
28. Meyers J.H., Chakravarti S., Schlesinger D., Illes Z., Waldner H., Umetsu S.E., et al. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 2005, 6:455-464.